Valuation Thiogenesis Therapeutics, Corp. OTC Markets

Stocks

Market Closed - OTC Markets 16:54:44 14/09/2026 +03			5-day change	1st Jan Change
0.3671 ^USD	-12.57%		-12.57%	-37.08%

08-07	Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-13	Thiogenesis Therapeutics Receives Fda Rare Pediatric Disease Designation for Tti-0102 for the Treatment of Leigh Syndrome	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025
Market Cap ¹	22.54	33.43	27.61	33.69
Change	-	48.3%	-17.4%	22.03%
Enterprise Value (EV) ¹	16.34	26.35	23.76	32.08
Change	-	61.23%	-9.83%	34.99%
P/E	-3.74x	-5.8x	-8.65x	-4.25x
PBR	3.77x	6.04x	8.06x	58.7x
PEG	-0x	0.3x	0.2x	-0x
Capitalization / Revenue	-	-	-	-
EV / Revenue	-	-	-	-
EV / EBITDA	-	-	-	-
EV / EBIT	-8.14x	-5.06x	-6.64x	-4.34x
EV / FCF	-	-	-	-
FCF Yield	-	-	-	-
Dividend per Share ³	-	-	-	-
Rate of return	-	-	-	-
EPS ³	-0.1552	-0.1294	-0.0693	-0.1528
Distribution rate	-	-	-	-
Net sales	-	-	-	-
EBITDA	-	-	-	-
EBIT ¹	-2.009	-5.206	-3.579	-7.395
Net income ¹	-3.924	-5.063	-3.146	-7.426
Net Debt ¹	-6.196	-7.076	-3.848	-1.616
Reference price ³	0.5800	0.7500	0.6000	0.6500
Nbr of stocks (in thousands)	38,862	44,571	46,017	51,836
Announcement Date	4/28/23 A	4/29/24 A	4/25/25 A	4/30/26 A

¹CAD in Million²USD in Million³CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LONZA GROUP AG	31.88x	5.74x	17.19x	1.02%	46.28B
IQVIA HOLDINGS INC.	34.31x	3.31x	14.29x	-.--%	43.85B
REVOLUTION MEDICINES, INC.	-19.53x	224.63x	-20.86x	-.--%	40.93B
BEONE MEDICINES AG	45.96x	5.31x	29.04x	-.--%	39.89B
CELLTRION, INC.	27.09x	7.81x	19.95x	0.42%	29.5B
MEDPACE HOLDINGS, INC.	34.82x	5.71x	25.95x	-.--%	17.09B
EUROFINS SCIENTIFIC SE	25.48x	2.19x	9.51x	1.05%	15.22B
TEMPUS AI, INC.	-55.89x	9.19x	224.28x	-.--%	14.05B
Average	15.51x	32.99x	39.92x	0.31%	30.85B
Weighted average by Cap.	20.30x	41.76x	24.53x	0.31%